John A. Phillips, MD, FACC, FSCAI, RPVI

Peripheral Procedures Using CorPath Robotic-Assisted Intervention at Ohio Health

09/05/2019

John A. Phillips , MD, FACC, FSCAI, RPVI;

I probably have 10-12 tibial cases under my belt. According to Corindus, in November 2018, we did the first tibial chronic total occlusion (CTO) with the system.

I probably have 10-12 tibial...

09/05/2019

Cath Lab Digest

Lower-Extremity Intervention

Advancements in Drug-Coated Balloon (DCB) Technology: BD’s 300mm Lutonix™ 018 DCB

10/09/2021

John A. Phillips , MD, FACC, FSCAI, RPVI;

We now have the technology to get through the lesion, treat it with effective devices, and be more efficient. We can also bear that fiduciary responsibility with greater ease, because the 300mm Lutonix™ (BD) allows us to use a single balloon...

We now have the technology to...

10/09/2021

Cath Lab Digest

Case Report

Robotic-Assisted Revascularization of the Posterior Tibial Artery in the Treatment of Peripheral Vascular Disease

09/16/2019

John A. Phillips , MD, FACC, FSCAI, RPVI;

This report describes the use of the CorPath GRX Robotic System to improve the safety of the interventionalist during percutaneous balloon angioplasty of an occluded posterior tibial artery.

This report describes the use of...

09/16/2019

Vascular Disease Management

Case Report

The Use of Renal Artery Stents in Aneurysmal Coronary Artery Disease

11/03/2023

John A. Phillips , MD, FACC, FSCAI, RPVI;

Jessica Pickard , BS, MS-IV;

Adam Reitz , DO;

This case report aims to shed light on the potential utilization of renal artery stents within aneurysmal coronary vessels to provide patients with ACAD first-line intervention in the setting of acute coronary syndrome.

This case report aims to shed...

11/03/2023

Cath Lab Digest

TACK ENDOVASCULAR REPAIR

Focal Stenosis, Focal Dissections – Focal Scaffolds?

06/26/2022

John A. Phillips , MD, FACC, FSCAI, RPVI;

A presentation by John A. Phillips, MD, FACC, FSCAI, System Director, OhioHealth Vascular Institute.

A presentation by John A....

06/26/2022

Cath Lab Digest

Aurine Tricarboxylic Acid (ATA) Disrupts DNase-Resistant Wound Biofilm Formed by Persister Clinical Isolate Bacteria

BACKGROUND: Biofilms represent a major threat to health care, and it is a clinical challenge to manage infected wounds resistant to antibiotic. Persistent bacterial phenotypes such as sma...

John A. Phillips , MD, FACC, FSCAI, RPVI;

Nandini Ghosh , PhD;

Jessica Smith , RN, MSN, BS ;

Subhadip Ghatak , PhD;

Sashwati Roy , PhD;

Chandan Sen , PhD;

Mohamed S. El Masry , MD, PhD;

08/19/2021

Editor's Corner

Zilver PTX in Long Lesions: Try the Jacket On

02/09/2018

John A. Phillips , MD, FACC, FSCAI, RPVI;

The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...

The authors evaluated their 1-...

02/09/2018

Vascular Disease Management